Comparing the effectiveness of midline and parasagittal interlaminar methods of epidural steroid injection in patients with lumbar spinal stenosis pai

Phase 2

Conditions: spinal stenosis with chronic pain.
Spinal stenosis, lumbar region is a medical classification as listed by WHO under the range
M48. 06

Registration Number: IRCT20131124015515N11

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 60

Inclusion Criteria

Patients with consent to participate in the study
Age 50 years and above
Radiculopathy
Confirming the diagnosis of lumbar spinal stenosis based on clinical examinations and radiographic findings
Evidence of lumbar spinal stenosis based on MRI according to Boden criteria
Patients suffering from moderate back pain and disability related to neurogenic lameness caused by central spinal stenosis.
Candidate patients for epidural steroid injection
Focal tenderness above the lumbar joint
Hyperextension pain
No history of neurological defects
Contraindications for back surgery
Failure to respond to traditional treatments (rest, drug therapy, physical therapy)

Exclusion Criteria

Foraminal and lateral recess stenosis without central canal stenosis
History of epidural steroid injection in the last six months
Coagulation disorders
Sensitivity to steroid or local anesthetic solution
Malignancy
Psychiatric problems and patient non-cooperation
Speech problems
Pregnancy
Surgical indication
Local skin infections in the operation area
Deformity of the spine
History of lumbar spine surgery
Cauda equina syndrome
Vertebral fracture, tumor or infection in the spine
Inflammatory spondylopathy

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual Analogue Scale (VAS) score (0 = no pain, 1-3 mild pain, 4-7 moderate pain and 8-10 severe pain). Timepoint: Before, one month and three months after injection. Method of measurement: Ask the patient.;Disability with the Oswestry Disability Index questionnaire. Timepoint: Before, one month and three months after injection. Method of measurement: Ask the patient.

Secondary Outcome Measures